181
Views
0
CrossRef citations to date
0
Altmetric
Review

Aromatase inhibitors in the pharmacotherapy of endometriosis

, , , , &
Pages 1067-1073 | Received 18 Jan 2023, Accepted 27 Apr 2023, Published online: 03 May 2023

References

  • Abu Hashim H. Potential role of aromatase inhibitors in the treatment of endometriosis. Int J Womens Health. 2014 Jul 21;6:671–680. PMID: 25092998; PMCID: PMC4113402. DOI:10.2147/IJWH.S34684
  • Ferrero S, Barra F, Leone Roberti Maggiore U. Current and emerging therapeutics for the management of endometriosis. Drugs. 2018 Jul;78(10):995–1012. PMID: 29946962. doi:10.1007/s40265-018-0928-0. .
  • Polyzos NP, Fatemi HM, Zavos A, et al. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol. 2011 Jun 21;9(1):90. PMID: 21693039; PMCID: PMC3142498. 10.1186/1477-7827-9-90.
  • Barra F, Grandi G, Tantari M, et al. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. Expert Opin Biol Ther. 2019 Apr;19(4):343–360. Epub 2019 Feb 27. PMID: 30763525. doi:10.1080/14712598.2019.1581761.
  • Nothnick WB. The emerging use of aromatase inhibitors for endometriosis treatment. Reprod Biol Endocrinol. 2011 Jun 21;9(1): PMID: 21693036; PMCID: PMC3135533:87. 10.1186/1477-7827-9-87
  • Colette S, Donnez J. Are aromatase inhibitors effective in endometriosis treatment? Expert Opin Investig Drugs. 2011 Jul;20(7):917–931. doi:10.1517/13543784.2011.581226. Epub 2011 May 2. PMID: 21529311.
  • Ferrero S, Alessandri F, Racca A, et al. Treatment of pain associated with deep endometriosis: alternatives and evidence. Fertil Steril. 2015 Oct;104(4):771–792. Epub 2015 Sep 10. PMID: 26363387. doi:10.1016/j.fertnstert.2015.08.031.
  • Sun S, Zhang H, Zhong P, et al. The effect of letrozole combined with dydrogesterone for endometriosis in china: a meta-analysis. BioMed Res Int. 2021 Dec 2;2021:9946060. doi: 10.1155/2021/9946060. PMID: 34901283; PMCID: PMC8660186.
  • Barra F, Scala C, Mais V, et al. Investigational drugs for the treatment of endometriosis, an update on recent developments. Expert Opin Investig Drugs. 2018 May;27(5):445–458. doi:10.1080/13543784.2018.1471135. Epub 2018 May 17. PMID: 29708812.
  • Lall Seal S, Kamilya G, Mukherji J, et al. Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review. Fertil Steril. 2011 Jan;95(1):291.e15–8. Epub 2010 Jun 25. PMID: 20579642. doi:10.1016/j.fertnstert.2010.05.021.
  • Garzon S, Laganà AS, Barra F, et al. Novel drug delivery methods for improving efficacy of endometriosis treatments. Expert Opin Drug Deliv. 2021 Mar;18(3):355–367. Epub 2020 Oct 27. PMID: 32981374. DOI:10.1080/17425247.2021.1829589.
  • Ferrero S, Evangelisti G, Barra F. Current and emerging treatment options for endometriosis. Expert Opin Pharmacother. 2018 Jul;19(10):1109–1125. doi:10.1080/14656566.2018.1494154. Epub 2018 Jul 5. PMID: 29975553.
  • Garzon S, Laganà AS, Barra F, et al. Aromatase inhibitors for the treatment of endometriosis: a systematic review about efficacy, safety and early clinical development. Expert Opin Investig Drugs. 2020 Dec;29(12):1377–1388. Epub 2020 Nov 26. PMID: 33096011. doi:10.1080/13543784.2020.1842356.
  • Słopień R, Męczekalski B. Aromatase inhibitors in the treatment of endometriosis. Prz Menopauzalny. 2016 Mar;15(1):43–47. doi:10.5114/pm.2016.58773. Epub 2016 Mar 29. PMID: 27095958; PMCID: PMC4828508.
  • Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012 Dec;98(6):1370–1379. doi:10.1016/j.fertnstert.2012.08.053. Epub 2012 Sep 19. PMID: 22999792; PMCID: PMC3513666.
  • Buggio L, Lazzari C, Monti E, et al. “Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review. Arch Gynecol Obstet. 2017 Sep;296(3):435–444. Epub 2017 Jun 29. PMID: 28664485. doi:10.1007/s00404-017-4448-z.
  • Hefler LA, Grimm C, van Trotsenburg M, et al. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study. Fertil Steril. 2005 Oct;84(4):1033–1036. doi:10.1016/j.fertnstert.2005.04.059. PMID: 16213868.
  • Higgins J, Altman D, Sterne J. Chapter 8: assessing risk of bias in included studies. In: In: Higgins J, Churchill R, Chandler J, and Cumpston M, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (Updated June 2017). Chichester: John Wiley and Sons; 2017. p. 1–73.
  • Urbánková I, Callewaert G, Blacher S et al, First delivery and ovariectomy affect biomechanical and structural properties of the vagina in the ovine model. Int Urogynecol J. 2019;30(3):455–464. DOI:10.1007/s00192-017-3535-9
  • Chichester: John Wiley and Sons; (2021)Urbankova I, Callewaert G, Blacher S, Deprest D, Hympanova L, Feola A, et al.First delivery and ovariectomy affect biomechanical and structural properties of the vagina in the ovine modelInt Urogynecol J. 2019;30:455–464. DOI: 10.1007/s00192-017-3535-9)
  • DrugBank. Anastrozole [ cited 20 Nov 2022]. Available from: https://go.drugbank.com/drugs/DB01217
  • Letrozole D; [cited 20 Nov 2022]. Available from: https://go.drugbank.com/drugs/DB01006.
  • Schultze-Mosgau MH, Waellnitz K, Nave R, et al. Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial. Hum Reprod. 2016 Aug;31(8):1713–1722. Epub 2016 Jun 19. PMID: 27390369. doi:10.1093/humrep/dew145.
  • Ailawadi RK, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril. 2004 Feb;81(2):290–296. PMID: 14967362. doi:10.1016/j.fertnstert.2003.09.029.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021 Jun;134:103–112. Epub 2021 Feb 9. PMID: 33577987. doi:10.1016/j.jclinepi.2021.02.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.